Pfizer Inc. and Albert Bourla got the upper hand in an early skirmish against Starboard Value LP — but the drugmaker and its embattled chief executive face a long war against an activist that hates to ...
Pfizer appointed a former chief executive officer at Vanguard, the drug giant's biggest investor, to its board on Tuesday as ...
W hat a twist! An activist investment fund, Starboard Value, has recently been pushing Pfizer (NYSE: PFE) to increase ...
The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...
Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...
Pfizer shares are on the up since US activist investor Starboard Value built up a stake in the drug maker. But strategic ...
Starboard Value alleged that Pfizer officials threatened legal action against two former top executives who had been working ...
On Oct. 6, The Wall Street Journal reported that activist investor group Starboard Value owns a stake in Pfizer ( PFE -0.61%) ...
The ongoing corporate battle between Pfizer and activist investment firm Starboard Value escalated on Thursday when Starboard ...
The corporate clash between Pfizer and Starboard Value heated up on Thursday when the activist investment firm pressed the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback